Get started
Author

Tomoya Akashi

Observed name: Akashi, Tomoya
ORCID: 0000-0002-2802-080X
Observed ORCID: 0000-0002-2802-080X
OpenAlex ID: A5022380895
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
2023 · Masahiro Hiraizumi, Tomoya Akashi, et al. · Nature Structural & Molecular Biology · 90
PDF
Layer II of placental syncytiotrophoblasts expresses MDR1 and BCRP at the apical membrane in rodents
2016 · Tomoya Akashi, Tomohiro Nishimura, et al. · Reproductive Toxicology · 12
L-type Amino Acid Transporter 1 (SLC7A5)-Mediated Transport of Pregabalin at the Rat Blood-Spinal Cord Barrier and its Sensitivity to Plasma Branched-Chain Amino Acids
2023 · Tomoya Akashi, Saki Noguchi, et al. · Journal of Pharmaceutical Sciences · 8
PDF
Contribution of equilibrative nucleoside transporter (ENT) 2 to fluorouracil transport in rat placental trophoblast cells
2016 · Akinori Takagi, Tomohiro Nishimura, et al. · Drug Metabolism and Pharmacokinetics · 8
Detection of Characteristic Phosphatidylcholine Containing Very Long Chain Fatty Acids in Cerebrospinal Fluid from Patients with X-Linked Adrenoleukodystrophy
2022 · Naoki Fujitani, Masayoshi Saito, et al. · Biological and Pharmaceutical Bulletin · 5
PDF
Increased neurotoxicity of high‐density lipoprotein secreted from murine reactive astrocytes deficient in a peroxisomal very‐long‐chain fatty acid transporter Abcd1
2023 · Naoki Fujitani, Tomoya Akashi, et al. · Journal of Inherited Metabolic Disease · 4
PDF
Structure-guided development of a potent human B0AT1 inhibitor effective in a mouse model of phenylketonuria
2026 · Takuya Imazu, Tomoya Akashi, et al. · Communications Biology · 3
Discovery of a potent, orally available furopyridine derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor
2024 · Shuichi Hagihara, Kouhei Ishizawa, et al. · Bioorganic & Medicinal Chemistry Letters · 3
Discovery of a potent orally available pyrazolopyridone derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor
2024 · Shuichi Hagihara, Kouhei Ishizawa, et al. · Bioorganic & Medicinal Chemistry Letters · 2
Subcellular localizations of efflux pumps, MDR1 and BCRP, in syncytiotrophoblast layers of rodent placenta
2016 · Masatoshi Tomi, Tomoya Akashi, et al. · Placenta · 1
Plasma concentration of LAT1 substrate amino acids affects the spinal cord transfer and the analgesic effect of pregabalin
2025 · Tomoya Akashi, Saki Noguchi, et al. · Drug Metabolism and Pharmacokinetics
神経障害性疼痛治療薬の血液脊髄関門透過機構とその薬効発現に与える影響 (要旨)
2022 · アカシ, トモヤ, Akashi, Tomoya, et al. · Institutional Repositories DataBase (IRDB)
PDF
神経障害性疼痛治療薬の血液脊髄関門透過機構とその薬効発現に与える影響 (審査報告)
2022 · アカシ, トモヤ, Akashi, Tomoya, et al. · Institutional Repositories DataBase (IRDB)
PDF
神経障害性疼痛治療薬の血液脊髄関門透過機構とその薬効発現に与える影響 (要約)
2022 · アカシ, トモヤ, Akashi, Tomoya, et al. · Institutional Repositories DataBase (IRDB)
PDF
WITHDRAWN: Evaluation of materno-fetal permeability of various compounds by fetus uptake index (FUI) method
2015 · Tomoya Akashi, Tomohiro Nishimura, et al. · Asian Journal of Pharmaceutical Sciences
PDF
Syncytiotrophoblast layer 2 expresses MDR1 and BCRP efflux transporters in rodent placenta
2015 · Masatoshi Tomi, Tomoya Akashi, et al. · Placenta
Works count: 16
Citation count: 136
H-index: 5
I10-index: 2
Year
Topic
Type